Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis-Reference-Cited by-同舟云学术

Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis

Published:2006-04-28 Issue:8 Volume:19 Page:1091-1100
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Reid-Nicholson Michelle,Iyengar Pratibha,Hummer Amanda J,Linkov Irina,Asher Marina,Soslow Robert A

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/3800620.pdf

Reference34 articles.

1. Ansari-Lari MA, Staebler A, Zaino RJ, et al. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Am J Surg Pathol 2004;28:160–167.

2. McCluggage WG, Jenkins D . p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma. Int J Gynecol Pathol 2003;22:231–235.

3. Negri G, Egarter-Vigl E, Kasal A, et al. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol 2003;27:187–193.

4. Wahlstrom T, Lindgren J, Korhonen M, et al. Distinction between endocervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine histological tissue specimens. Lancet 1979;2:1159–1160.

5. Dallenbach-Hellweg G, Lang-Averous G, Hahn U . The value of immunohistochemistry in the differential diagnosis of endometrial carcinomas. APMIS Suppl 1991;23:91–99.

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of the prognostic nomogram and treatment recommendation in patients with mixed endometrial carcinoma treated with hysterectomy;Biomolecules and Biomedicine;2024-07-08

2. EPPK1 as a Prognostic Biomarker in Type I Endometrial Cancer and Its Correlation with Immune Infiltration;International Journal of General Medicine;2024-04

3. An Immunohistochemical Study to assess the Expression of Estrogen and Progesterone Receptor in Endometrial hyperplasia and Endometrial carcinoma compared to normal Endometrium: A Prospective Pathological Study;Research Journal of Pharmacy and Technology;2024-02-20

4. Estrogen Receptor (ER) and Progesterone Receptor (PgR) Expression in Endometrial Cancer—An Immunohistochemical Assessment;Diagnostics;2024-02-01

5. Endometrial Carcinogenesis;Gynecologic and Obstetric Pathology;2024